| 产品详情 |
| Edit |   |
|---|
| Product Name | Zoledronic Acid Monohydrate |
|---|
| Description | Purity ≥98.5%. Zoledronic acid (zoledronate) is a bisphosphonate bone resorption inhibitor, an inhibitor of farnesyl diphosphate (FPP) synthase which results in downstream inhibition of osteoclast activity and reduced bone resorption and turnover. It has been used to treat postmenopausal osteoporosis, Paget?s disease, hypercalcemia, and along with cancer chemotherapy to treat bone damage caused by cancer that has spread to the bones. Loss on Drying: 5-7% Identification (IR): Conforms to structure Solubility: Water: ≥2mg/ml |
|---|
| Size | 5g, 10g, 25g |
|---|
| Concentration | n/a |
|---|
| Applications | n/a |
|---|
| Other Names | P,P?-[1-Hydroxy-2-(1H-imidazol-1-yl)ethylidene]bisphosphonic acid monohydrate; Zoledronate monohydrate; [1-hydroxy-2-(1H-imidazol-1-yl)ethane-1,1-diyl]bis(phosphonic acid) monohydrate |
|---|
| Gene, Accession, CAS # | n/a |
|---|
| Catalog # | 292165 |
|---|
| Price | |
|---|
| Order / More Info | Zoledronic Acid Monohydrate from UNITED STATES BIOLOGICAL |
|---|
| Product Specific References | n/a |
|---|
| 产品资料 |
|
|